An antibiotic-free plasmid vector platform for non-viral DNA delivery
Dan Zhao, Zakary D. Carden, Yifei Wang, Cole S. Hudson, Perry A. Maza, Dana Cyril-Ramirez, Yong Li · 2027
Read An antibiotic-free plasmid vector platform for non-viral DNA delivery by Dan Zhao, Zakary D. Carden, Yifei Wang, Cole S. Hudson, Perry A. Maza, Dana Cyril-Ramirez, Yong Li (2027) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13631514.txt.
Description
Dan Zhao led a 2027 paper introducing pIR, a small, scalable plasmid platform for non-viral DNA delivery that drops antibiotic resistance genes. Standard plasmid backbones rely on such genes for selection, raising regulatory and biosafety worries, while commercial antibiotic-free systems cost much and limit tinkering. The new platform uses an R6K gamma origin plus a Cre enzyme system in a bacterial host. The resistance gene is cut out when arabinose is added, leaving a vector that keeps replicating.
The team confirmed the strain by PCR, genome sequencing, and protein blotting, then showed the platform working in cell culture and in mice. A reporter plasmid performed in transfected cells and in mouse muscle after electroporation. A tumor-antigen version was tested in tumor-bearing mice, and a GLP-1 version raised blood hormone levels. The platform offers an open alternative to licensed systems, with animal proof across three uses.
Catalog record
| CREATOR | Dan Zhao, Zakary D. Carden, Yifei Wang, Cole S. Hudson, Perry A. Maza, Dana Cyril-Ramirez, Yong Li |
|---|---|
| YEAR | 2027 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |